Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA537650
Max Phase: Preclinical
Molecular Formula: C22H35Cl2N3
Molecular Weight: 339.53
Molecule Type: Small molecule
Associated Items:
ID: ALA537650
Max Phase: Preclinical
Molecular Formula: C22H35Cl2N3
Molecular Weight: 339.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Cl.Cn1cc(C2CCN(CCCN3CCCCC3)CC2)c2ccccc21
Standard InChI: InChI=1S/C22H33N3.2ClH/c1-23-18-21(20-8-3-4-9-22(20)23)19-10-16-25(17-11-19)15-7-14-24-12-5-2-6-13-24;;/h3-4,8-9,18-19H,2,5-7,10-17H2,1H3;2*1H
Standard InChI Key: QMGIYPYKKBMQEC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 339.53 | Molecular Weight (Monoisotopic): 339.2674 | AlogP: 4.23 | #Rotatable Bonds: 5 |
Polar Surface Area: 11.41 | Molecular Species: BASE | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.71 | CX LogP: 3.71 | CX LogD: 1.09 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.81 | Np Likeness Score: -0.83 |
1. Hayashi R, Ohmori E, Isogaya M, Moriwaki M, Kumagai H.. (2006) Design and synthesis of selective alpha1B adrenoceptor antagonists., 16 (15): [PMID:16723224] [10.1016/j.bmcl.2006.05.002] |
Source(1):